Literature DB >> 3316404

Measurement of antibodies to Candida albicans as a screening test for humoral immunodeficiency.

D I Phillips1, N Matthews.   

Abstract

In screening for defects in humoral immunity, as well as measuring serum immunoglobulins it is advisable to have some measure of antibody production, e.g., immunising with a test antigen and measuring the antibody response some days later. However, this delay may be inconvenient and requires a second blood sample. An alternative is to test for antibody to a widespread commensal organism to which the patient must have been repeatedly exposed. The measurement of antibody to E. coli by haemagglutination has been previously used for this purpose. We report here that an equally good and simpler alternative is to measure antibodies to the commensal Candida albicans by immunofluorescence. Using a polyvalent conjugate, all 114 blood donors tested had antibody titres greater than 8 to C. albicans; similar responses were noted in 20 children (aged 6 months-16 years) without recurrent infections. In contrast, anti-candida responses were low or absent as expected in patients with hypogammaglobulinaemia but also in some patients with other immunodeficiency diseases. Overall candida immunofluorescence closely paralleled E. coli haemagglutination.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3316404     DOI: 10.1016/0022-1759(87)90422-4

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  3 in total

1.  Smoking, humoral immunity, and ulcerative colitis.

Authors:  E D Srivastava; J R Barton; S O'Mahony; D I Phillips; G T Williams; N Matthews; A Ferguson; J Rhodes
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

Review 2.  Diagnosis of invasive mycoses in severely immunosuppressed patients.

Authors:  R Rüchel
Journal:  Ann Hematol       Date:  1993-07       Impact factor: 3.673

3.  A case of hereditary combined deficiency of complement components C6 and C7 in man.

Authors:  B P Morgan; J P Vora; A J Bennett; J P Thomas; N Matthews
Journal:  Clin Exp Immunol       Date:  1989-03       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.